305 related articles for article (PubMed ID: 31999897)
1. Inhibition of Sphingolipid Synthesis as a Phenotype-Modifying Therapy in Cystic Fibrosis.
Mingione A; Dei Cas M; Bonezzi F; Caretti A; Piccoli M; Anastasia L; Ghidoni R; Paroni R; Signorelli P
Cell Physiol Biochem; 2020 Jan; 54(1):110-125. PubMed ID: 31999897
[TBL] [Abstract][Full Text] [Related]
2. Myriocin modulates the altered lipid metabolism and storage in cystic fibrosis.
Signorelli P; Pivari F; Barcella M; Merelli I; Zulueta A; Dei Cas M; Rosso L; Ghidoni R; Caretti A; Paroni R; Mingione A
Cell Signal; 2021 May; 81():109928. PubMed ID: 33482299
[TBL] [Abstract][Full Text] [Related]
3. Cystic Fibrosis Defective Response to Infection Involves Autophagy and Lipid Metabolism.
Mingione A; Ottaviano E; Barcella M; Merelli I; Rosso L; Armeni T; Cirilli N; Ghidoni R; Borghi E; Signorelli P
Cells; 2020 Aug; 9(8):. PubMed ID: 32781626
[TBL] [Abstract][Full Text] [Related]
4. Anti-inflammatory action of lipid nanocarrier-delivered myriocin: therapeutic potential in cystic fibrosis.
Caretti A; Bragonzi A; Facchini M; De Fino I; Riva C; Gasco P; Musicanti C; Casas J; Fabriàs G; Ghidoni R; Signorelli P
Biochim Biophys Acta; 2014 Jan; 1840(1):586-94. PubMed ID: 24141140
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of ceramide de novo synthesis by myriocin produces the double effect of reducing pathological inflammation and exerting antifungal activity against A. fumigatus airways infection.
Caretti A; Torelli R; Perdoni F; Falleni M; Tosi D; Zulueta A; Casas J; Sanguinetti M; Ghidoni R; Borghi E; Signorelli P
Biochim Biophys Acta; 2016 Jun; 1860(6):1089-97. PubMed ID: 26922830
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic effect and autophagy regulation of myriocin in nonalcoholic steatohepatitis.
Yang RX; Pan Q; Liu XL; Zhou D; Xin FZ; Zhao ZH; Zhang RN; Zeng J; Qiao L; Hu CX; Xu GW; Fan JG
Lipids Health Dis; 2019 Oct; 18(1):179. PubMed ID: 31639005
[TBL] [Abstract][Full Text] [Related]
7. Disruption of sphingolipid metabolism augments ceramide-induced autophagy in preeclampsia.
Melland-Smith M; Ermini L; Chauvin S; Craig-Barnes H; Tagliaferro A; Todros T; Post M; Caniggia I
Autophagy; 2015 Apr; 11(4):653-69. PubMed ID: 25853898
[TBL] [Abstract][Full Text] [Related]
8. An ANGPTL4-ceramide-protein kinase Cζ axis mediates chronic glucocorticoid exposure-induced hepatic steatosis and hypertriglyceridemia in mice.
Chen TC; Lee RA; Tsai SL; Kanamaluru D; Gray NE; Yiv N; Cheang RT; Tan JH; Lee JY; Fitch MD; Hellerstein MK; Wang JC
J Biol Chem; 2019 Jun; 294(23):9213-9224. PubMed ID: 31053639
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of ceramide de novo synthesis reduces liver lipid accumulation in rats with nonalcoholic fatty liver disease.
Kurek K; Piotrowska DM; Wiesiołek-Kurek P; Łukaszuk B; Chabowski A; Górski J; Zendzian-Piotrowska M
Liver Int; 2014 Aug; 34(7):1074-83. PubMed ID: 24106929
[TBL] [Abstract][Full Text] [Related]
10. Myriocin treatment affects lipid metabolism in skeletal muscles of rats with streptozotocin-induced type 1 diabetes.
Kurek K; Garbowska M; Ziembicka DM; Łukaszuk B; Rogowski J; Chabowski A; Górski J; Żendzian-Piotrowska M
Adv Med Sci; 2017 Mar; 62(1):65-73. PubMed ID: 28189121
[TBL] [Abstract][Full Text] [Related]
11. Myriocin treatment of CF lung infection and inflammation: complex analyses for enigmatic lipids.
Caretti A; Vasso M; Bonezzi FT; Gallina A; Trinchera M; Rossi A; Adami R; Casas J; Falleni M; Tosi D; Bragonzi A; Ghidoni R; Gelfi C; Signorelli P
Naunyn Schmiedebergs Arch Pharmacol; 2017 Aug; 390(8):775-790. PubMed ID: 28439630
[TBL] [Abstract][Full Text] [Related]
12. Defective CFTR increases synthesis and mass of sphingolipids that modulate membrane composition and lipid signaling.
Hamai H; Keyserman F; Quittell LM; Worgall TS
J Lipid Res; 2009 Jun; 50(6):1101-8. PubMed ID: 19144995
[TBL] [Abstract][Full Text] [Related]
13. Lipid metabolism in cystic fibrosis.
Worgall TS
Curr Opin Clin Nutr Metab Care; 2009 Mar; 12(2):105-9. PubMed ID: 19209467
[TBL] [Abstract][Full Text] [Related]
14. Sphingolipid synthetic pathways are major regulators of lipid homeostasis.
Worgall TS
Adv Exp Med Biol; 2011; 721():139-48. PubMed ID: 21910087
[TBL] [Abstract][Full Text] [Related]
15. Effect of myriocin on plasma sphingolipid metabolism and atherosclerosis in apoE-deficient mice.
Hojjati MR; Li Z; Zhou H; Tang S; Huan C; Ooi E; Lu S; Jiang XC
J Biol Chem; 2005 Mar; 280(11):10284-9. PubMed ID: 15590644
[TBL] [Abstract][Full Text] [Related]
16. Serine palmitoyltransferase inhibitor myriocin induces the regression of atherosclerotic plaques in hyperlipidemic ApoE-deficient mice.
Park TS; Rosebury W; Kindt EK; Kowala MC; Panek RL
Pharmacol Res; 2008 Jul; 58(1):45-51. PubMed ID: 18611440
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Ceramide Synthesis Reduces α-Synuclein Proteinopathy in a Cellular Model of Parkinson's Disease.
Mingione A; Pivari F; Plotegher N; Dei Cas M; Zulueta A; Bocci T; Trinchera M; Albi E; Maglione V; Caretti A; Bubacco L; Paroni R; Bottai D; Ghidoni R; Signorelli P
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34208778
[TBL] [Abstract][Full Text] [Related]
18. Sphingolipid synthesis is involved in autophagy in Saccharomyces cerevisiae.
Yamagata M; Obara K; Kihara A
Biochem Biophys Res Commun; 2011 Jul; 410(4):786-91. PubMed ID: 21703229
[TBL] [Abstract][Full Text] [Related]
19. Autophagy augmentation alleviates cigarette smoke-induced CFTR-dysfunction, ceramide-accumulation and COPD-emphysema pathogenesis.
Bodas M; Pehote G; Silverberg D; Gulbins E; Vij N
Free Radic Biol Med; 2019 Feb; 131():81-97. PubMed ID: 30500419
[TBL] [Abstract][Full Text] [Related]
20. Serine palmitoyltransferase inhibitor myriocin induces growth inhibition of B16F10 melanoma cells through G(2) /M phase arrest.
Lee YS; Choi KM; Choi MH; Ji SY; Lee S; Sin DM; Oh KW; Lee YM; Hong JT; Yun YP; Yoo HS
Cell Prolif; 2011 Aug; 44(4):320-9. PubMed ID: 21645154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]